What is ESLAW's market cap?

$132.90K, based on the Sep 23 close of $0.06.

What sector is ESLAW in?

Healthcare, in the Biotechnology industry.

NASDAQ · ESLAWHealthcareBiotechnology

Estrella Immunopharma, Inc. Warrant (ESLAW)

$0.0600−14.29%

Close Sep 23, 2026 · split-adjusted

Sep 23, 2026$0.06▲ 15.83% in range

Sep 30, 2025Low $0.05 · High $0.24Sep 23, 2026

What changed · written from our data

As of Sep 28, 2026

Estrella Immunopharma, Inc. Warrant closed at $0.06 on Sep 23, down 14.29%, 74.5% below its highest close since Oct 2. Volume of 5.1K shares was 1.58× its 20-day average (above normal).

Split-adjusted performance: -22.6% over one month.

Short interest was 29.6K shares at the Sep 15 settlement (869.3 days to cover).

Market cap$132.9K2.2M shares

Revenue · quarter$0.00—

Diluted EPS$-0.05—

P/E · TTM—

Net margin—

Dividend yieldNone

Range since Oct 20.05 – 0.24−74.5% from high

Volume5.1K1.58× 20-day avg

Volatility · 60d293.3%Annualised

Short % of float—869.3 days to cover

Net cash$146.7KCash $146.7K

Next earnings—Not scheduled

Split-adjusted performance

1W −14.3%1M −22.6%3M −57.5%6M —YTD +20.0%1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Biotechnology

Percentile among 139 companies (100 = best)

6-month momentum—

Revenue growth—

Net margin—

Value (low P/E)—

Size—

Industry medians: 6-month return −3.9%, revenue growth +9.0%, net margin −231.7%, P/E 20.2×.

Short interest

Details →

Shares short29.6K−0.7% vs prior

Days to cover869.3Settled Sep 15

% of float—

Short vol. 10d100.0%of daily volume

Closest peers by size in Biotechnology

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
ESLAWEstrella Immunopharma, Inc. Warrant	$0.0600	−14.29%	—	—	—	—	$132.9K
TVGNWTevogen Inc. Warrant	$0.0601	−7.54%	+84.4%	—	—	—	$1.1M	Compare
RVMDWRevolution Medicines, Inc. Warrant	$11.22	−3.48%	+586.2%	—	—	—	$123.9M	Compare

News about Estrella Immunopharma, Inc. Warrant

All news →

ESLA: Abbott Cooper PLLC Announces Investigation on Behalf of Estrella Immunopharma, Inc. StockholdersGlobeNewswire Inc. · Jul 9, 2026▼ Negative

Quick answers

What does Estrella Immunopharma, Inc. Warrant do?: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
What is ESLAW's market cap?: $132.90K, based on the Sep 23 close of $0.06.
What sector is ESLAW in?: Healthcare, in the Biotechnology industry.

About Estrella Immunopharma, Inc. Warrant

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

HQ: Emeryville, CAListed Oct 2, 2023estrellabio.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology